MacuHealth is a supplement specially formulated for the prevention of Macular Degeneration vision loss. Unlike most other vitamins and nutritional supplements on the market today, which are not universally accepted to work or experts argue about what the exact benefits are, MacuHealth is one of the most highly regarded supplements available because it has been extensively researched by leading global eye research institutions.
It is prescribed by optometrists and ophthalmologists worldwide because of its unquestioned effectiveness, both as a prevention of future vision loss from macular degeneration, as well as for patients with macular degeneration to slow down the progression. MacuHealth is an affordable way to prevent the leading cause of vision loss in Americans over the age of 60.
What is in MacuHealth?
MacuHealth is comprised of the right combination of vital pigments found in the macula of the eye and is the only dietary supplement containing all three critical nutrients which are:
- Lutein-Naturally found in kale, spinach, and turnip
- Zeaxanthin-Naturally found in kale, spinach, and turnip
- Meso-zeanxanthin-Naturally found in fresh trout and Salmon skin
When the macula of the eye is deficient in the three nutrients that provide the correct pigments for it, it can lead to permanent vision loss with macular degeneration. Consistent use of MacuHealth over a six month period has been shown in clinical trials to restore the pigment of the macula to normal levels in just six months.
Impact of Eye Vitamins in Alzheimer’s Disease
Reports of a study shown that patients with mild to moderate Alzheimer’s disease exhibit significantly less macular pigment, poorer vision, and a higher occurrence of age-related macular degeneration compared to people without Alzheimer’s disease. A study was conducted to investigate the impact of supplementation with the macular carotenoids on macular pigment, and vision and cognitive function in patients with Alzheimer’s disease compared with controls of similar age.
A randomized, double-blind clinical trial with placebo and active arms. 31 Alzheimer’s disease patients and 31 age-similar control subjects were supplemented for six months with either Supplemental Macular Carotenoids (10 mg meso-zeaxanthin; 10 mg lutein; 2 mg zeaxanthin) or placebo (sunflower oil). Macular pigment was measured using dual-wavelength autofluorescence (Heidelberg Spectralis®). Serum lutein, zeaxanthin, and meso-zeaxanthin were quantified by high performance liquid chromatography. Visual function was assessed by best corrected visual acuity and contrast sensitivity. Cognitive function was assessed using a battery of cognition tests, including the Cambridge Neuropsychological Test Automated Battery
Results of the study shown that supplementation with the macular carotenoids (meso-zeaxanthin, lutein and zeaxanthin) benefits patients with Alzheimer’s disease, in terms of clinically meaningful improvements in visual function and in terms of macular pigment augmentation. Read more about the study here.